- Learn how AI-driven approaches integrate multiomics data, including genomics, proteomics, and transcriptomics, to identify potential drug targets and disease biomarkers for complex diseases.
- Explore how AI models synthesize cross-omic data and real-time multiomic information to uncover novel biological mechanisms, identify potential biomarkers and enable precision medicine.
Sponsor(s):
Solix Technologies
Speaker(s):
Moderator
Raju Pusapati
Vice President, Life Sciences
Solix Technologies Inc.
Kiran Nistala
Head, Functional Genomics
Alkermes
Harris Bell-Temin
Director, Proteomics
Johnson & Johnson Innovative Medicine
Arthur Liberzon
Director, AI Research Lead for Omics, Oncology Data Science
AstraZeneca
Time:
12:45 PM - 1:15 PM
Agenda Track No.:
Track 1
Session Type:
General Session (Presentation)